Domain Therapeutics develops small molecules targeting G-coupled protein receptors.

Biotechnology

Health Care

Pharmaceutical

Therapeutics

Domain Therapeutics

Domain Therapeutics' headquarters in Illkirch, France

Clément Jodeau

Jean-Marc Simon

Asmaa Boudribila

Samira EL FAROUK, PhD

Stanislas-Léonard Malmezat

Nathalie Lenne

Stephan Schann

Orphée Blanchard

Stanislas MALMEZAT

Anne-Laure Blayo

Yann PFEIFFER

Dounia CHRAA, Ph.D

Francesco Bergami, PhD

Antoine Italiano

John Stagg

James Huang

J. Silvio Gutkind

Aurélie Maisner

Michel Bouvier

Emmanuel Fiessinger

Laurence Rulleau

Roberto De Ponti

Sylvie Ryckebusch

The Research and Development Team at Domain Therapeutics is responsible for discovering and optimizing small molecule drugs that target G-coupled protein receptors. Team members engage in various specialized roles, ranging from molecular pharmacology, medicinal chemistry, and immuno-oncology to preclinical research. This involves cross-functional collaboration to conduct experiments, analyze data, and advance compounds from initial concept to clinical development.

Research and Development Team

The Scientific Advisory and Research team at Domain Therapeutics provides expert guidance on research strategies and methodologies, evaluates scientific progress, and identifies emerging opportunities in the field of G-coupled protein receptors. They collaborate closely to drive innovation, support chemical and biological research, and ensure the development of effective small molecule therapeutics.

Scientific Advisory and Research

The Management and Oversight team at Domain Therapeutics is responsible for strategic decision-making, corporate governance, legal compliance, financial oversight, project management, procurement, and internal communications to ensure the smooth and efficient development of small molecules targeting G-coupled protein receptors.

Management and Oversight

The Business Development team at Domain Therapeutics is responsible for identifying and securing partnerships, licensing deals, and collaborations to advance the company's portfolio of small molecules targeting G-coupled protein receptors. Key functions include market analysis, negotiation, and fostering relationships with pharmaceutical and biotechnology companies.

Business Development

The Clinical and Medical Operations team at Domain Therapeutics oversees the planning, execution, and management of clinical trials targeting G-coupled protein receptors. The team ensures clinical study integrity, coordinates biomarker strategy, manages project timelines, and supports medical oversight to advance therapeutic candidates through clinical development stages.

Clinical and Medical Operations

The Leadership Team at Domain Therapeutics is responsible for setting the strategic direction and vision of the company, focusing on the development and commercialization of small molecules targeting G-coupled protein receptors. This team, comprised of key executive roles such as the CEO, CFO, and Vice Presidents of Strategic Portfolio Management, drives decision-making related to investment, operational efficiency, and overall portfolio management to ensure the successful advancement of therapeutic candidates.

Leadership Team

Domain Therapeutics

Org chart

Board & advisors

Teams

Research and Development Team

Scientific Advisory and Research

Management and Oversight

Business Development

Clinical and Medical Operations

Leadership Team

Offices

Domain Therapeutics

Org chart

Board & advisors

Teams

Research and Development Team

Scientific Advisory and Research

Management and Oversight

Business Development

Clinical and Medical Operations

Leadership Team

Offices

Related companies